Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
iQure Pharma Inc. logo — Providing attractive therapies to patients and physicians wh...

iQure Pharma Inc.

Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors

Founded 2019 United States Princeton, United States 7 employees Debt Financing Total: $2.17M Biotechnology, Health and Wellness +1

General Information

Company Name iQure Pharma Inc.
Founded Year 2019
Location United States Princeton, United States +2
Employees 7
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Debt Financing
Social

Get notified when iQure Pharma Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iQure Pharma Inc.

is a biotechnology and pharmaceutical startup based in the United States, founded in 2019. The company's slogan "Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors" encapsulates its mission. iQure Pharma is focused on developing new therapeutic solutions by leveraging academic research and industry expertise. The company's core competencies include scouting for innovative compounds from academic research, evaluating out-licensing opportunities with big pharma and biotech, and selecting compounds with significant attractive target profiles for commercialization. Additionally, iQure Pharma is dedicated to driving preclinical and clinical development activities while ensuring regulatory and quality compliance. In October 11, 2023, iQure Pharma secured a $1.20M Venture Round investment from Ventura BioMed Investors and OKG Capital. This investment signifies the confidence that these investors have in iQure Pharma's potential for delivering impactful therapies and generating attractive returns. With its unique positioning and focus on bridging academia and industry, iQure Pharma holds promise for both patients and investors seeking meaningful healthcare innovations and sustainable financial growth.

Taxonomy: pharmaceutical research, technology transfer, out-licensing, biotech partnerships, clinical development, regulatory compliance, investment placement, commercialization, patient-centered, financial analysis, therapeutics evaluation, academic collaborations

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 05 Apr 2024
Venture Round •••••• 2
Investor
•••• •••• 		11 Oct 2023
Grant •••••• 1 •••• •••• 31 Aug 2022
Series A •••••• 3
Investor Investor
•••• •••• 		31 Aug 2022
Convertible Note •••••• 1 •••• •••• 14 Sep 2020

View All 6 Funding Rounds

iQure Pharma Inc. Alternatives & Competitors

iQure Pharma Inc. vs
Humonix Biosciences, Inc.
Humonix Biosciences, Inc. United States

Accelerating and de-risking ophthalmic drug development

Seed
7 employees
Biopharma, Biotechnology
iQure Pharma Inc. vs
MDS Pharma Services
MDS Pharma Services United States

MDS Pharma Services – The world's premier provider of innovative drug discovery and development solu...

647 employees
Biotechnology, Health Care
iQure Pharma Inc. vs
Vernalis
Vernalis United Kingdom

We develop and apply fragment and structure-based methods to solve problems in drug discovery

Series Unknown
253 employees
Biotechnology, Pharmaceutical

FAQ About iQure Pharma Inc.

Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors
iQure Pharma Inc. was founded in 2019.
iQure Pharma Inc. is headquartered in Princeton, United States.
iQure Pharma Inc. operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
iQure Pharma Inc. has approximately 7 employees.
iQure Pharma Inc. has completed 6 funding rounds, raising a total of $2.17M. The latest funding stage is Debt Financing.
Top alternatives and competitors to iQure Pharma Inc. include Humonix Biosciences, Inc., MDS Pharma Services, Vernalis, PHARMASSIST LTD, Boston Biomedical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iQure Pharma Inc. and Humonix Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iQure Pharma Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy